Lyell Immunopharma, Inc. Human Resources Contracts & Agreements
12 Contracts & Agreements
- Bonus & Incentive Agreements (5 contracts)
- Compensation Agreements (2)
- Separation Agreements (2)
- Severance Agreements (3)
- Non-Employee Director Compensation Policy (Filed With SEC on November 7, 2023)
- Release and Separation Agreement (Filed With SEC on August 8, 2023)
- Separation, Transition and General Release Agreement, by and between Elizabeth Homans and Lyell Immunopharma, Inc., dated December 15, 2022 (Filed With SEC on December 16, 2022)
- Severance Waiver by and between the Registrant and Stephen Hill, dated April 19, 2022 (Filed With SEC on May 10, 2022)
- Lyell Immunopharma, Inc. Officer Severance Plan (Filed With SEC on March 29, 2022)
- Lyell Immunopharma, Inc. 2021 Non-Employee Director Compensation Policy (Filed With SEC on June 9, 2021)
- Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Lyell Immunopharma, Inc. 2021 Equity Incentive Plan (Filed With SEC on June 9, 2021)
- Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Lyell Immunopharma, Inc. 2021 Equity Incentive Plan (Filed With SEC on June 9, 2021)
- Lyell Immunopharma, Inc. 2021 Equity Incentive Plan (Filed With SEC on June 9, 2021)
- Lyell Immunopharma, Inc. Officer Severance Plan (Filed With SEC on May 25, 2021)
- Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise and Restricted Stock Award Agreement under the Lyell Immunopharma, Inc. 2018 Equity Incentive Plan (Filed With SEC on May 25, 2021)
- Lyell Immunopharma, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on May 25, 2021)
